- Home
- NRSN vs CLIR Comparison
NRSN vs CLIR Comparison
Compare NRSN & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- CLIR
- Stock Information
- Founded
- NRSN 2017
- CLIR 2008
- Country
- NRSN Israel
- CLIR United States
- Employees
- NRSN N/A
- CLIR N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- NRSN Health Care
- CLIR Industrials
- Exchange
- NRSN Nasdaq
- CLIR Nasdaq
- Market Cap
- NRSN 29.8M
- CLIR 30.7M
- IPO Year
- NRSN 2021
- CLIR 2012
- Fundamental
- Price
- NRSN $0.98
- CLIR $0.82
- Analyst Decision
- NRSN Buy
- CLIR Strong Buy
- Analyst Count
- NRSN 2
- CLIR 1
- Target Price
- NRSN $14.00
- CLIR $2.00
- AVG Volume (30 Days)
- NRSN 202.0K
- CLIR 152.9K
- Earning Date
- NRSN 12-17-2025
- CLIR 11-19-2025
- Dividend Yield
- NRSN N/A
- CLIR N/A
- EPS Growth
- NRSN N/A
- CLIR N/A
- EPS
- NRSN N/A
- CLIR N/A
- Revenue
- NRSN N/A
- CLIR $2,983,000.00
- Revenue This Year
- NRSN N/A
- CLIR $13.13
- Revenue Next Year
- NRSN N/A
- CLIR $143.88
- P/E Ratio
- NRSN N/A
- CLIR N/A
- Revenue Growth
- NRSN N/A
- CLIR 19.03
- 52 Week Low
- NRSN $0.80
- CLIR $0.46
- 52 Week High
- NRSN $2.60
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- NRSN 37.32
- CLIR 46.89
- Support Level
- NRSN $0.89
- CLIR $0.75
- Resistance Level
- NRSN $0.97
- CLIR $0.97
- Average True Range (ATR)
- NRSN 0.07
- CLIR 0.09
- MACD
- NRSN -0.01
- CLIR -0.01
- Stochastic Oscillator
- NRSN 26.22
- CLIR 30.09
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.